List of insiders holdings for VYNE Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
2023-11-13 08:30:21 | 8,909,033 0 |
8,909,033 | Form 3 |
| 2 | Vivo Capital VIII LLC Vivo Capital Surplus Fund VIII L.P. Vivo Capital Fund VIII L.P. 10% Owner |
2020-06-11 17:09:43 | 3,643,824 0 |
3,643,824 | Form 13G |
| 3 | Remeditex Ventures LLC 10% Owner |
2018-01-29 16:19:55 | 2,761,663 0 |
2,761,663 | Form 4 |
| 4 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2022-02-14 19:33:57 | 2,425,604 0 |
2,425,604 | Form 13G |
| 5 | Hadar Ilan CFO and Country Manager |
2020-03-11 17:56:34 | 546,910 0 |
546,910 | Form 4 |
| 6 | Hirsch Stanley Director |
2020-04-07 17:22:35 | 201,410 328,609 |
530,019 | Form 4 |
| 7 | Cha Albert Director |
2018-01-29 16:14:57 | 0 486,695 |
486,695 | Form 4 |
| 8 | Domzalski David PRESIDENT AND CEO |
2025-04-02 16:15:11 | 445,563 0 |
445,563 | Form 4 |
| 9 | Presidio Partners 2007 GP L.P. Presidio Partners 2007 (Parallel) L.P. Presidio Partners 2007 L.P. Collier David J Watson James F Sohail Faysal A. Former 10% Owner |
2018-07-26 19:11:02 | 0 200,972 |
200,972 | Form 4 |
| 10 | Harsch Mutya CHIEF LEGAL OFFICER AND GC |
2025-04-02 16:15:17 | 135,501 0 |
135,501 | Form 4 |
| 11 | Whitcup Scott M Director |
2019-08-08 21:17:23 | 134,099 0 |
134,099 | Form 4/A |
| 12 | Stuart Iain CHIEF SCIENTIFIC OFFICER |
2025-04-02 16:15:20 | 122,593 0 |
122,593 | Form 4 |
| 13 | Zeronda Tyler CHIEF FINANCIAL OFFICER |
2025-04-02 16:15:24 | 118,493 0 |
118,493 | Form 4 |
| 14 | Saik Andrew Chief Financial Officer |
2021-06-02 16:31:40 | 116,468 0 |
116,468 | Form 4 |
| 15 | Wiley Matthew T. Chief Commercial Officer |
2021-07-02 16:36:53 | 109,246 0 |
109,246 | Form 4 |
| 16 | Spellman Mary Chief Medical Officer |
2018-12-12 18:43:44 | 96,000 0 |
96,000 | Form 4 |
| 17 | MCGIRR DAVID W J Director |
2019-08-08 21:17:22 | 65,780 0 |
65,780 | Form 4/A |
| 18 | BERNS PAUL L Director |
2019-08-08 21:18:55 | 65,780 0 |
65,780 | Form 4/A |
| 19 | Ebel Ted Director |
2019-08-08 21:39:57 | 53,423 0 |
53,423 | Form 4/A |
| 20 | BALL KRISTINE M See Remarks |
2019-12-16 17:14:49 | 52,534 0 |
52,534 | Form 4/A |
| 21 | Kwon Paul Chief Scientific Officer |
2019-12-16 17:13:19 | 52,534 0 |
52,534 | Form 4/A |
| 22 | LEPORE PATRICK G Director |
2025-01-16 18:06:19 | 51,472 0 |
51,472 | Form 4 |
| 23 | Royston Aaron Director |
2019-08-08 21:24:22 | 22,500 0 |
22,500 | Form 4/A |
| 24 | Bright Rex Director |
2021-07-20 17:05:03 | 20,500 0 |
20,500 | Form 4 |
| 25 | Bruno Anthony D Director |
2024-12-13 16:15:14 | 20,000 0 |
20,000 | Form 4 |
| 26 | Sandoval Elisabeth Director |
2024-12-13 16:15:17 | 20,000 0 |
20,000 | Form 4 |
| 27 | BARBARI SHARON Director |
2024-12-13 16:15:20 | 20,000 0 |
20,000 | Form 4 |
| 28 | Basta Steven L Director |
2024-12-13 16:15:26 | 20,000 0 |
20,000 | Form 4 |
| 29 | Borowski Christine Director |
2024-12-13 16:15:33 | 20,000 0 |
20,000 | Form 4 |
| 30 | Krasnow Ronald A. See Remarks |
2019-12-13 21:58:18 | 15,819 0 |
15,819 | Form 4 |
| 31 | FMR LLC See Remark 1 |
2019-02-13 11:58:21 | 333 0 |
333 | Form 13G |
| 32 | venBio Global Strategic Fund II L.P. 10% Owner |
2020-04-16 12:47:05 | 0 0 |
0 | Form 13D |
| 33 | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
2019-02-14 14:09:26 | 0 0 |
0 | Form 13G |